A Saccharomyces cerevisiae strain with a disrupted yeast cadmium resistance factor (YCFI) gene (DTY168) is hypersensitive to cadmium. YCF1 resembles the human multidrug resistance-associated protein MRP (63% amino acid similarity), which confers resistance to various cytotoxic drugs by lowering the intracellular drug concentration. Whereas the mechanism of action of YCF1 is not known, MRP was recently found to transport glutathione Sconjugates across membranes. Here we show that expression of the human MRP cDNA in yeast mutant DTY168 cells restores cadmium resistance to the wild-type level. Transport of S-(2,4-dinitrobenzene)-glutathione into isolated yeast microsomal vesicles is strongly reduced in the DTY168 mutant and this transport is restored to wild-type level in mutant cells expressing MRP cDNA. We find in cell fractionation experiments that YCF1 is mainly localized in the vacuolar membrane in yeast, whereas MRP is associated both with the vacuolar membrane and with other internal membranes in the transformed yeast cells. Our results indicate that yeast YCF1 is a glutathione S-conjugate pump, like MRP, and they raise the possibility that the cadmium resistance in yeast involves cotransport of cadmium with glutathione derivatives.
Several recent studies indicate that the human MRP is one of these elusive GS-X pumps: (i) Overexpression of MRP in human cancer cells resulted in an increased ATP-dependent transport of GSH S-conjugates into isolated plasma membrane vesicles (16, 17) . (ii) Transfection of an MRP cDNA in pig kidney epithelial cells increased the basolateral export of a GSH S-conjugate (18) . ( iii) The export of anti-cancer drugs by MRP requires intracellular GSH (19, 20) . (iv) Overexpression of MRP increased the efflux of GSH from human lung cancer cells exposed to arsenite (20) . The latter result supports the hypothesis that the GS-X pump transports arsenite as a complex with GSH (17, 20) and provides an explanation for the observed cross-resistance of some MRP-overexpressing cells against arsenite (8) .
The yeast Saccharomyces cerevisiae contains a gene, denoted yeast cadmium resistance factor 1 (YCF1) that encodes a transporter with extensive homology (63% amino acid similarity) with human MRP (21) . Disruption of the YCF1 gene resulted in a yeast strain (DTY168) hypersensitive to cadmium (21) . In this paper we demonstrate that heterologous expression of a human MRP cDNA can complement this deficiency. Furthermore, transport experiments with microsomal vesicles revealed that DTY168 cells had a strongly decreased GS-X transport activity, which was also complemented by human MRP. These data indicate that MRP and YCF1 are not only closely related in sequence but also in function. ( 10 Ci/mol; 1 Ci = 37 GBq) was synthesized as described (22) and purified using a C18 reversed phase column. Other chemicals were from Sigma, unless stated otherwise.
MATERIALS AND METHODS Chemicals. [14C]-S-(2,4-dinitrobenzene)-glutathione ([14C]DNB-GS)
Strains. Cloning in Escherichia coli was performed in strain DH5a. The isogenic yeast strains DTY7 (Mata, ura 3-52, leu2-3,-112, his6) and DTY168 (Mata, ycflA::hisG, ura 3-52, leu2-3,-112, his6) were used for heterologous expression of the MRP cDNA.
Construction of the MRP Expression Vector. To excise the untranslated 5' end of the cDNA encoding MRP (7) , two primers were synthesized. The sense primer MRP1S [positions 196 to 212 as published (7) iTo whom reprint requests should be addressed.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. §1734 solely to indicate this fact. Experiments with cadmium were done in the absence of DTT and BSA, which had no affect on DNB-GS uptake. The calculation of the Km for DNB-GS was done using the Enzfitter program (version 1.05; Elsevier Biosoft, Cambridge, U.K.). Subcellular Fractionation of Yeast Extracts. To prepare crude yeast extracts, cells growing exponentially in SD medium without uracil (200 ml cultures; OD600 = 0.5-0.7) were used. Subsequent steps were according to the fractionation protocol described by Kolling and Hollenberg (27) with the modification that DTT was omitted in all steps as this made the NADPH dependent cytochrome c reductase assay unreliable. Briefly, lysis of the cells was achieved by vortexing in STED10 [10% (wt/vol) sucrose/10 mM Tris Cl, pH 7.6/10 mM EDTA/1 mM PMSF/1 ,ul leupeptin/1 ,1 pepstatin A/1 ,ul aprotinin] in the presence of glass beads for 3 min. The cell extract was cleared (700 g, 10 min), and loaded onto a sucrose gradient prepared as follows. STED53, STED35, and STED20 [53, 35, and 20% (wt/vol) sucrose, respectively, 10 mM Tris-Cl (pH 7.6), 1 mM EDTA] were layered in this order in a centrifuge tube (4 ml each; Beckman SW41 rotor). After loading with extract (0.5 ml), gradients were spun for 17 h at 30,000 rpm at 4°C. Fractions (700 ,lI) were collected from the top of the gradient. Marker proteins were detected by Western blotting and incubation with rabbit polyclonal antibodies against the yeast plasma membrane ATPase (PMATPase), the Golgi protein dipeptidyl aminopeptidase A (DPAPA), and a monoclonal antibody against MRP (MoAb MRPrl; ref. 28) . The activity of the endoplasmic reticulum marker NADPHdependent cytochrome c reductase was measured in a reaction mixture consisting of 40 mM KPi (pH 7.8), 0.4 mM NADPH, 0.1% (vol/vol) Triton X-100, 1 ,tM Rotenone, 70 ,iM cytochrome c, complemented with 10-20 ,ul of the gradient fractions. The increase in absorbance at 550 nm was followed for 7.5 min in a Cobas analyzer (Roche Clinical Laboratories, Burlington, NC). The reaction was linear over this time period. Activity of the vacuolar marker a-mannosidase was measured as described (29) , with the modification that 4-methylumbelliferyl-a-D-mannopyranoside was used as the substrate. (Fig. 1, lanes 1 and 2) . The molecular mass of human MRP made in the pig kidney epithelial cell line LLC-PK1 transfected with MRP cDNA is approximately 190 kDa (Fig. 1, lane 3 (28) . Protein antibody interaction was detected using the enhanced chemiluminescence technique. The source of the membrane fractions is indicated over the lanes.
RESULTS
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activity of the GSH conjugates DNB-GS and LTC4 into isolated plasma membrane vesicles prepared from such cells (17, 32) . ATP-dependent transport of DNB-GS was also shown in membrane vesicles isolated from an S. cerevisiae secretory mutant (3), indicating that these cells also contain a GS-X pump. YCF1 could be responsible for this activity, based on its homology with MRP. To verify this, microsomal vesicles (a mixture of vesicles derived from internal membranes and the plasma membrane) were prepared from DTY168, DTY168(MRP), and DTY7 cells and assayed for ATPdependent DNB-GS uptake. Microsomal vesicles from DTY168(MRP) and DTY7 showed a time-dependent accumulation of DNB-GS. This accumulation continued for at least 12 min for DTY168(MRP) and DTY7 (Fig. 2) . The uptake activity of the DTY168(MRP) vesicles over 12 min was roughly 1.5-fold higher than that of the wild-type DTY7 vesicles, whereas microsomes isolated from DTY168 cells accumulated DNB-GS only at a very low rate. The ATP-dependent DNB-GS uptake in DTY168(MRP) vesicles is a saturable process (Fig. 3) . The apparent Km value was calculated to be 23 ± 3 ,uM. Uptake of DNB-GS was not stimulated by the nonhydrolyzable ATP analogue AMP-PNP and was inhibited by 1 mM vanadate (Table 2 ). In contrast, NH4', which dissipates the pH gradient build-up by proton pumps (33) and thus secondarily affects transport processes dependent on activated proton gradients, did not inhibit the uptake of DNB-GS. Decyl-GS inhibited the uptake of DNB-GS almost completely, oxidized GSH (GSSG) was less effective, whereas GSH had no effect. Probenecid and sulfinpyrazone, which effectively inhibits MRP mediated export from mammalian cells (18, 34) , also had an inhibitory effect. Subcellular Localization of MRP in DTY168(MRP). Despite several attempts with various anti-MRP antibodies we were not able to reliably immunolocalize MRP in DTY168(MRP) cells using either fluorescence or electron microscopy. To determine the subcellular localization of MRP in DTY168(MRP) cells we therefore fractionated cell extracts on a sucrose gradient. Fractions collected from the gradient were assayed by Western blot analysis for the presence of MRP, plasma membrane ATPase (PMATPase), and the Golgi protein dipeptidyl aminopeptidase A (DPAPA). Endoplasmic reticulum membranes were identified by measuring NADPHdependent cytochrome c reductase (cyt. red.) activity and vacuolar membranes by determining the a-mannosidase activity. Fig. 4 shows the data from a typical fractionation experiment. Cytochrome c reductase activity was enriched in fractions 2-8 ( Fig. 4D) , whereas most of the PMATPase was detected in fractions [10] [11] [12] [13] [14] [15] [16] (Fig. 4A) . The bulk of MRP was found in fractions 6-12 (Fig. 4B) , the same fractions where the DPAPA marker protein was found (Fig. 4C) . a-Mannosidase activity partially overlapped with the presence of MRP and was detected in fractions [6] [7] [8] [9] [10] (Fig. 4D) . These data indicate that the majority of the MRP protein is associated with intracellular membranes, but not primarily with endoplasmic reticulum or plasma membrane.
We have previously shown that plants contain a GS-X pump in the vacuolar membrane and not in the plasma membrane (4). As our fractionation experiments showed an overlap between the a-mannosidase activity and the presence of MRP we investigated whether vacuolar membranes contain functionally active MRP. Vacuoles were isolated from DTY7, DTY168(MRP), and DTY168 cells using a flotation gradient. The vacuolar fractions had a 2-to 3-fold higher specific a-mannosidase activity than the microsomal fractions, indicating that they were enriched for vacuolar membranes. Fig. 5 shows that the vacuoles isolated from DTY7 cells accumulated DNB-GS in a time and ATP-dependent manner, whereas this accumulation was 2-and 5-fold lower in vacuoles isolated from DTY168(MRP) and DTY168 cells, respectively. Comparison of the uptake rates in vacuoles and microsomes as a function of a-mannosidase activity after an incubation of 8 min indicated that in the DTY7 cells most activity was associated with vacuolar membranes (data not shown). In contrast, in the vacuolar fraction from the DTY168(MRP) cells, the specific transport activity per microgram of protein was lower than in the microsomal vesicles (compare Figs. 2 and 5) . Furthermore, the ratio of DNB-GS transport activity to a-mannosidase activity was lower in the vacuolar fraction of DTY168(MRP) than in the microsomal vesicles (data not shown). We conclude that most of YCF1 is localized in the vacuolar membrane. In contrast, as already suggested by the fractionation experiment, MRP is associated both with the vacuole and with other internal membranes. The fractionation in Fig. 4 suggests that there is no significant amount of MRP in the yeast plasma membrane. This conclusion is supported by observations with monobromobimane, a compound that reacts readily with GSH. After incubation of DTY7, DTY168(MRP), or DTY168 cells with monobromobimane the resulting product, GSbimane, was only detected intracellularly and not in the medium (data not shown).
DISCUSSION
In this report we demonstrate that a human MRP cDNA can restore both GSH S-conjugate transport activity and cadmium tolerance in yeast cells lacking the YCF1 gene. This suggests that yeast YCF1 and human MRP are functional homologues. The properties of MRP in yeast resemble those of MRP produced in mammalian cells (17): (i) DNB-GS uptake is strongly ATP dependent, and the nonhydrolysable ATP analogue AMP-PNP cannot drive DNB-GS uptake in microsomal vesicles; (ii) uptake is strongly inhibited by decyl-GS, weakly by GSSG, and not at all by GSH; (iii) the apparent Km value of MRP in yeast for DNB-GS (23 ,uM (35) . Localization of MRP in the plasma membrane of mammalian cells may therefore be due to overexpression of MRP, resulting in an overflow of protein toward the plasma membrane. This type of behavior is typical of proteins that reside in the trans-Golgi network (36) .
Sulfinpyrazone and probenecid, known inhibitors of multispecific organic anion transport in living cells (37) are specific inhibitors of DNB-GS and cytotoxic drug export from cells overexpressing MRP (18, 34) . We now show that both compounds are also directly inhibiting MRP in vitro in microsomes isolated from yeast. Probenecid and sulfinpyrazone inhibited DNB-GS uptake only by 10-20% and 40%, respectively, in microsomes isolated from wild-type DTY7 cells, suggesting that these compounds can discriminate between YCF1 and MRP (data not shown).
It has been shown that MRP can confer arsenite resistance to human cells (8) , and arsenite increased the rate of GSH efflux from MRP overexpressing cells (20) . Since it is known that arsenite can react with GSH to form an As(SG)3 complex (38) , it is most likely that this complex is transported by MRP (20) . There is also indirect evidence for transport of a cisplatin-GSH complex by MRP (15 (42) . However, only a mutant in which the yAP1 gene was disrupted showed cadmium hypersensitivity. (ii) Heavy metal complexing proteins such as metallothioneins have been described in animals, fungi, and plants. Expression of the Arabidopsis thaliana metallothionein genes in DTY168 cells rescues the cadmium sensitivity of these cells (unpublished results). (iii) Phytochelatins, GSH-derived peptides able to complex heavy metals, are present in fungi and plants. (iv) Finally, recent results suggest that members of the ABC transporter family can also play an important role in the detoxification of cadmium. In Schizosaccharomycespombe HMT1, a "single half' ABC-transporter localized in the vacuolar membrane, is associated with heavy metal tolerance. Detoxification occurs by transport of a complex of phytochelatins and cadmium across the vacuolar membrane. Transport of GSH and cadmium could not be detected (43, 44) .
The fact that MRP confers cadmium resistance to DTY168 cells in combination with the strong decrease in GS-X pump activity in the DTY168 mutant is compatible with the idea that MRP is directly involved in the transport of a cadmium-GSH complex. However, as yet, there is no experimental support for this idea. We were unable to detect ATP-dependent uptake of cadmium in the presence of GSH in our microsomal uptake system under various conditions. Furthermore, inhibition of DNB-GS transport by GSH (1 mM) and Cd2t (100-300 ,uM) was also weak (data not shown). It is therefore possible that the role of MRP in cadmium detoxification is an indirect one. In plants it has been shown that a Cd2+/H+ antiporter exhibiting a high affinity for cadmium is localized in the vacuolar membrane (45) , and that phytochelatins are transported into the vacuole by a transport system that may correspond to a GSH-conjugate ATPase (ref. 46 ; R.T., E. Grill, and E.M., unpublished data). Cd2+ transport due to a proton antiporter was also detected in S. pombe (44) . Therefore, an alternative role of MRP in yeast cadmium tolerance could be that cadmium is detoxified by a H+/Cd2+ antiporter and subsequently complexed with a cadmium binding molecule transported by MRP. Further studies on the substrate specificities of MRP are needed to settle this matter.
Note Added in Proof. A recent paper by Li et al. (47) shows that the yeast YCF1 protein is localized in the vacuolar membrane and that it is a glutathione S-conjugate transporter, in full agreement with our findings.
